(CercleFinance.com) – Eurobio Scientific announces that it has been notified of the achievement of a 2% stake in the capital by EchiumBio Holding BV, the holding company of Wietse Mulder, CEO of GenDx, a company that the Group acquired last October.
EchiumBio has indeed crossed, via purchases of shares on the market, the statutory threshold of 2% and held 230,956 Eurobio Scientific shares as of February 3, 2023.
‘The acquisition of GenDx was made entirely in cash and the fact that Wietse is entering our capital after only a few months is a very positive signal. ‘ says Denis Fortier, CEO of Eurobio Scientific. “We were delighted to welcome him to our management team and it is a great pleasure to have him now also as a partner. It is a strong sign of confidence in our common project. ‘
Eurobio Scientific’s board of directors will recommend to appoint Wietse Mulder as a director at the next General Assembly.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
